[The influence of centrally acting drugs on flicker fusion frequency]. 1975

C von Littrow, and K Feller, and K Graupner, and E Kálmán

From the research results given we may conclude that the flicker fusion frequency is reduced not only by tranquillisers but also by neuroleptic drugs. The records obtained of the effect of the dosage can be seen as a measure of the efficiency of this method. It should be established by means of similar experiments, by including additional substances, in which regions of the cortico-retinal system the site of action should be presumed to be.

UI MeSH Term Description Entries
D008620 Meprobamate A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603) Dapaz,Equanil,Meprospan,Miltown,Méprobamate Richard,Tranmep,Visano
D011619 Psychotropic Drugs A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). Psychoactive Agent,Psychoactive Agents,Psychoactive Drug,Psychopharmaceutical,Psychopharmaceuticals,Psychotropic Drug,Psychoactive Drugs,Agent, Psychoactive,Agents, Psychoactive,Drug, Psychoactive,Drug, Psychotropic,Drugs, Psychoactive,Drugs, Psychotropic
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D002746 Chlorpromazine The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. Aminazine,Chlorazine,Chlordelazine,Chlorpromazine Hydrochloride,Contomin,Fenactil,Largactil,Propaphenin,Thorazine,Hydrochloride, Chlorpromazine
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005425 Flicker Fusion The point or frequency at which all flicker of an intermittent light stimulus disappears. Flicker Fusions,Fusion, Flicker,Fusions, Flicker
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C von Littrow, and K Feller, and K Graupner, and E Kálmán
March 1968, The British journal of ophthalmology,
C von Littrow, and K Feller, and K Graupner, and E Kálmán
April 1954, Klinische Wochenschrift,
C von Littrow, and K Feller, and K Graupner, and E Kálmán
January 1953, Arbeitsphysiologie; internationale Zeitschrift fur angewandte Physiologie,
C von Littrow, and K Feller, and K Graupner, and E Kálmán
August 1964, British journal of pharmacology and chemotherapy,
C von Littrow, and K Feller, and K Graupner, and E Kálmán
May 1972, British journal of pharmacology,
C von Littrow, and K Feller, and K Graupner, and E Kálmán
January 1988, Journal of cardiovascular pharmacology,
C von Littrow, and K Feller, and K Graupner, and E Kálmán
February 1988, British medical journal (Clinical research ed.),
C von Littrow, and K Feller, and K Graupner, and E Kálmán
January 1968, Therapia Hungarica (English edition),
C von Littrow, and K Feller, and K Graupner, and E Kálmán
January 1977, Acta medica Polona,
C von Littrow, and K Feller, and K Graupner, and E Kálmán
March 2004, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!